These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein. Lorente E, Barriga A, García-Arriaza J, Lemonnier FA, Esteban M, López D. PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006036. PubMed ID: 29084215 [Abstract] [Full Text] [Related]
3. Development of a novel multi-epitope vaccine based on capsid and envelope protein against Chikungunya virus. Ma S, Zhu F, Wen H, Rao M, Zhang P, Peng W, Cui Y, Yang H, Tan C, Chen J, Pan P. J Biomol Struct Dyn; 2024 Aug; 42(13):7024-7036. PubMed ID: 37526203 [Abstract] [Full Text] [Related]
6. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. Adhikari UK, Rahman MM. Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145 [Abstract] [Full Text] [Related]
10. In silico analyses and experimental validation of the MHC class-I restricted epitopes of Ebolavirus GP. Liu Y, Sun B, Wang J, Sun H, Lu Z, Chen L, Lan M, Xu J, Pan J, Shi J, Sun Y, Zhang X, Wang J, Jiang D, Yang K. Int Immunol; 2022 Jun 04; 34(6):313-325. PubMed ID: 35192720 [Abstract] [Full Text] [Related]
16. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis. Bordbar A, Bagheri KP, Ebrahimi S, Parvizi P. Infect Genet Evol; 2020 Jun 04; 80():104189. PubMed ID: 31931259 [Abstract] [Full Text] [Related]